“alnara-pharmaceuticals” Archives

in
Entry Author Date Location
Alnara Pharmaceuticals Lands $35,000,000 Series B Funding Round 01/28/10 Boston
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News 06/03/09 Boston
Alnara Pharma Completes Key Cystic Fibrosis Drug Trial, “Extremely Encouraged” by Results 05/28/09 Boston
Genzyme Shrinks Gene Therapy Effort, Expands Oncology; BioVex Raises $40M For Cancer-Fighting Viruses; Biogen Looks to Future of MS Franchise; & More Boston-Area Life Sciences News 04/01/09 Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started 03/25/09 Boston
N.E. VC Investment Sinks in 4th Quarter—No Surprise—And Lists of the Region’s Top Deals and Dealmakers 01/20/09 Boston
Biotech Veteran Talks of Hedge Fund Investing, Boston Celtics, and Hot Companies 12/18/08 Boston
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News 11/05/08 Boston
Alnara Pharmaceuticals Aims to Make Biotech Drugs You Can Swallow, And That Go Right Where They Belong 10/30/08 Boston
Page 2 of 2 « previous page